AstraZeneca PLC (AZN)
161.69
-0.44
(-0.27%)
USD |
NYSE |
Sep 01, 13:12
AstraZeneca Cash and Short Term Investments (Quarterly) : 7.675B for March 31, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 7.675B |
| December 31, 2025 | 5.741B |
| September 30, 2025 | 8.182B |
| June 30, 2025 | 7.108B |
| March 31, 2025 | 5.395B |
| December 31, 2024 | 5.654B |
| September 30, 2024 | 4.93B |
| June 30, 2024 | 7.076B |
| March 31, 2024 | 8.021B |
| December 31, 2023 | 5.962B |
| September 30, 2023 | 5.115B |
| June 30, 2023 | 5.812B |
| March 31, 2023 | 6.462B |
| December 31, 2022 | 6.405B |
| September 30, 2022 | 4.898B |
| June 30, 2022 | 4.887B |
| March 31, 2022 | 5.823B |
| December 31, 2021 | 6.398B |
| September 30, 2021 | 7.149B |
| June 30, 2021 | 15.63B |
| March 31, 2021 | 7.765B |
| December 31, 2020 | 7.992B |
| September 30, 2020 | 8.446B |
| June 30, 2020 | 6.115B |
| March 31, 2020 | 4.165B |
| Date | Value |
|---|---|
| December 31, 2019 | 6.218B |
| September 30, 2019 | 4.78B |
| June 30, 2019 | 6.247B |
| March 31, 2019 | 4.958B |
| December 31, 2018 | 5.68B |
| September 30, 2018 | 4.262B |
| June 30, 2018 | 3.81B |
| March 31, 2018 | 3.871B |
| December 31, 2017 | 4.582B |
| September 30, 2017 | 5.211B |
| June 30, 2017 | 6.263B |
| March 31, 2017 | 3.672B |
| December 31, 2016 | 5.929B |
| September 30, 2016 | 4.025B |
| June 30, 2016 | 4.651B |
| March 31, 2016 | 4.107B |
| December 31, 2015 | 6.855B |
| September 30, 2015 | 4.607B |
| June 30, 2015 | 4.549B |
| March 31, 2015 | 3.722B |
| December 31, 2014 | 7.176B |
| September 30, 2014 | 5.957B |
| June 30, 2014 | 5.778B |
| March 31, 2014 | 5.164B |
| December 31, 2013 | 10.05B |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| GSK Plc | 4.122B |
| Johnson & Johnson | 20.76B |
| Eli Lilly & Co. | 8.95B |
| Merck & Co., Inc. | 7.182B |
| Novo Nordisk A/S | 6.880B |